Tuberculosis (TB) Clinical Trial
Official title:
A Non-interventional, Prospective Clinical Performance Study of the QuantiFERON Access Kit to Demonstrate Clinical Accuracy Compared to a CE-marked In-Vitro Diagnostic Medical Device, in Participants With Varying Risk Factors for TB Infection and Disease.
Approximately 225 samples, obtained from participants with varying risk factors for TB infection and disease, will be tested using the QFT Access Kit and the comparator device QFT-Plus.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Not yet recruiting |
NCT06272812 -
A Study to Evaluate the Efficacy, Safety and Immunogenicity of MTBVAC in IGRA Positive Adolescents and Adults Living in a TB Endemic Region.
|
Phase 2 | |
| Active, not recruiting |
NCT01875952 -
Diagnosis and Treatment of Co-infection With Human Immunodeficiency Virus /Latent Tuberculosis Infection (HIV/TBL)
|
Phase 4 | |
| Completed |
NCT03929705 -
Assessing the Ability of the T-SPOT®.TB Test
|
||
| Recruiting |
NCT03808636 -
Innovative Reagents for Improving Rapid Diagnosis of Mycobacterial Infections
|
||
| Completed |
NCT01879163 -
Phase I Trial Evaluating Safety and Immunogenicity of MVA85A-IMX313 Compared to MVA85A in BCG Vaccinated Adults
|
Phase 1 | |
| Completed |
NCT00146744 -
Safety and Immunogenicity of GSK Biological's Candidate Tuberculosis Vaccine Mtb72F/AS02A in Healthy PPD-positive Adults
|
Phase 2 | |
| Completed |
NCT00291889 -
Safety and Immunogenicity of GSK Biological's Candidate Tuberculosis Vaccine Mtb72F/AS02 in Healthy PPD-negative Adults.
|
Phase 1 | |
| Recruiting |
NCT04333485 -
Tuberculosis (TB) Aftermath
|
N/A | |
| Completed |
NCT00730795 -
Safety and Immunogenicity of a Candidate Tuberculosis (TB) Vaccine Given to PPD-Negative Adults
|
Phase 1 | |
| Completed |
NCT00600782 -
Immunogenicity and Safety of a Candidate Tuberculosis (TB) Vaccine Given to Healthy Adults in a TB-endemic Region
|
Phase 2 |